P827: EFFICACY AND SAFETY OF ROMIPLOSTIM ADDED TO IMMUNOSUPPRESSIVE THERAPY AS A FIRST-LINE TREATMENT IN PATIENTS WITH APLASTIC ANEMIA: A PHASE 2/3 CLINICAL TRIAL

oleh: H. Yamazaki, J. W. Lee, J. H. Jang, M. Sawa, M. Kizaki, Y. Tomiyama, K. Nagafuji, K. Usuki, J.-P. Gau, Y. Morita, J.-L. Tang, H. Chang, M. Noshiro, A. Matsuda, K. Ozawa, K. Mitani, Y. Kanda, S. Nakao